Inventor · name-matched record
SONG GENGSHEN
4 granted patents·8 pending applications·0 citations·filing 2023–2025
53Inventor score
Files withHANGZHOU TIANLONG PHARMACEUTICAL CO LTD6BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD4BEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD2
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
12 records- 0164US2026002160A1Sirna targeting and regulating pcsk9 gene expression and use thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0263US12545637B2Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its compositionBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Granted Feb 10, 2026·0 cites·24 claims
- 0361US2026009035A1Galnac compound containing ribose ring or its derivative structure and oligonucleotide conjugate thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0459US2026085317A1Sirna for targeted inhibition of agt gene expression and use thereof in treating hypertensionHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0557US12576099B2Ribose-modified cap analog and use thereofBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2025·Granted Mar 17, 2026·0 cites·5 claims
- 0657US2026007613A1Long-acting low-toxicity novel cationic lipid compounds and composition thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0755US2026007601A1Ionizable cationic lipid compound and composition for delivering nucleic acid and use thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0853US2026008746A1Cationic lipid compound with high efficiency, low toxicity and stable expression, and composition comprisng sameHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0953US2026049317A1GalNAc Compound Containing Triazole Structure and Oligonucleotide Conjugate ThereofBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2025·Application pending·0 cites
- 1053US2026085320A1Galnac monomer comprising ribose ring or derivative structure thereof and use thereof in liver-targeted delivery of small nucleic acid drugsBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2025·Application pending·0 cites
- 1151US12551500B2C6′-substituted locked nucleic acid-modified cap analog and use thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2025·Granted Feb 17, 2026·0 cites·20 claims
- 1249US12514920B1Respiratory syncytial virus mRNA vaccine, and preparation method therefor and use thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2025·Granted Jan 6, 2026·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when SONG GENGSHEN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →